Market Tracker

02/22 4:59pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

14.40
Delayed Data
As of 4:00pm ET
 -0.50 / -3.36%
Today’s Change
9.23
Today|||52-Week Range
23.80
+40.08%
Year-to-Date

Today’s Trading

Previous close14.90
Today’s open14.70
Day’s range14.34 - 14.96
Volume255,136
Average volume (3 months)263,648
Market cap$434.1M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-103.55%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-0.19-1.59%
KPTIKaryopharm Therapeut...-0.14-1.32%
LBIOLion Biotechnologies...+0.05+0.70%
COLLCollegium Pharmaceut...-0.32-2.20%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts